Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients

Clinical trial NCT06931080 · RECRUITING

Trial details

NCT number: NCT06931080
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)

Start date: 2025-04-30
Primary completion: 2027-12-01
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.